<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03594201</url>
  </required_header>
  <id_info>
    <org_study_id>KYXM-201803</org_study_id>
    <nct_id>NCT03594201</nct_id>
  </id_info>
  <brief_title>A Retrospective Study on the Effect of Male Progressive Sperm Count After Semen Pretreatment on ICSI Fertilization Outcome</brief_title>
  <official_title>A Retrospective Study on the Effect of Male Progressive Sperm Count After Semen Pretreatment on ICSI Fertilization Outcome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Reproductive &amp; Genetic Hospital of CITIC-Xiangya</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Reproductive &amp; Genetic Hospital of CITIC-Xiangya</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators plan to retrospectively analyze clinical data from 14,189 fresh ICSI cycles
      in Reproductive and Genetic Hospital of CITIC-Xiangya from January 2016 to December 2017.The
      investigators will regard total progressive sperm number of 2 x 10^6 after pretreatment as
      the boundary value, and will divide total progressive sperm number of 2 x 10^6 after
      pretreatment into 2 x 10^6 or higher and &lt; 2 x 10^6 groups, and will further divide &lt; 2 x
      10^6 group into: = 0, (0,10^6], (10^6, 2 x 10^6) three groups. Propensity score matching will
      be used to balance the baseline data between four groups. The matching variables are age,
      female BMI, AFC, AMH and ICSI.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Actual">January 3, 2018</completion_date>
  <primary_completion_date type="Actual">December 31, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>high quality embryo rate for ICSI</measure>
    <time_frame>two years</time_frame>
    <description>rate of embryo grade above 6CI on the third day after fertilization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>fertilization rate of ICSI</measure>
    <time_frame>two years</time_frame>
    <description>number of fertilized oocytes/ number of metaphase II oocytes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>normal fertilization rate of ICSI</measure>
    <time_frame>two years</time_frame>
    <description>number of 2PN fertilized oocytes/ number of metaphase II oocytes</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">12215</enrollment>
  <condition>Sperm Count, Low</condition>
  <condition>Reproductive Sterility</condition>
  <arm_group>
    <arm_group_label>group1</arm_group_label>
    <description>A+B grade sperm count after treatment=0</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group2</arm_group_label>
    <description>0＜A+B grade sperm count after treatment≤10^6</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group3</arm_group_label>
    <description>10^6＜A+B grade sperm count after treatment＜2*10^6</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group4</arm_group_label>
    <description>A+B grade sperm count after treatment≥2*10^6</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>semen pretreatment</intervention_name>
    <description>semen pretreatment</description>
    <arm_group_label>group1</arm_group_label>
    <arm_group_label>group2</arm_group_label>
    <arm_group_label>group3</arm_group_label>
    <arm_group_label>group4</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Infertile couples take ART treament due to poor male semen quality.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  infertility female and sterility male for reproductive treatment

        Exclusion Criteria:

          -  chromosomal abnormalities

          -  none retrieval oocyte

          -  none oocyte for ICSI

          -  Recurrent abortion

          -  female age≥37 years

          -  Assisted hatching

          -  abnormal oocyte zona pellucida

          -  In Vitro Maturation

          -  AZF microdeletion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Liang Hu, MD,PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Reproductive &amp; Genetic Hospital of CITIC-Xiangya</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Reproductive &amp; Genetic Hospital of CITIC-XIANGYA</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410008</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>July 11, 2018</study_first_submitted>
  <study_first_submitted_qc>July 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 20, 2018</study_first_posted>
  <last_update_submitted>May 19, 2019</last_update_submitted>
  <last_update_submitted_qc>May 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ICSI, progressive sperm count, embryo</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Oligospermia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

